Literature DB >> 26505218

Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α.

Daniel J Purcell1, Swati Chauhan1, Diane Jimenez-Stinson1, Kathleen R Elliott1, Tenzin D Tsewang1, Young-Ho Lee1, Brian Marples1, David Y Lee1.   

Abstract

Coactivator-associated arginine methyltransferase 1 (CARM1) is known to promote estrogen receptor (ER)α-mediated transcription in breast cancer cells. To further characterize the regulation of ERα-mediated transcription by CARM1, we screened CARM1-interacting proteins by yeast two-hybrid. Here, we have identified an E3 ubiquitin ligase, DAZ (deleted in azoospermia)-interacting protein 3 (DZIP3), as a novel CARM1-binding protein. DZIP3-dependent ubiquitination of histone H2A has been associated with repression of transcription. However, ERα reporter gene assays demonstrated that DZIP3 enhanced ERα-mediated transcription and cooperated synergistically with CARM1. Interaction with CARM1 was observed with the E3 ligase RING domain of DZIP3. The methyltransferase activity of CARM1 partially contributed to the synergy with DZIP3 for transcription activation, but the E3 ubiquitin ligase activity of DZIP3 was dispensable. DZIP3 also interacted with the C-terminal activation domain 2 of glucocorticoid receptor-interacting protein 1 (GRIP1) and enhanced the interaction between GRIP1 and CARM1. Depletion of DZIP3 by small interfering RNA in MCF7 cells reduced estradiol-induced gene expression of ERα target genes, GREB1 and pS2, and DZIP3 was recruited to the estrogen response elements of the same ERα target genes. These results indicate that DZIP3 is a novel coactivator of ERα target gene expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26505218      PMCID: PMC4664229          DOI: 10.1210/me.2015-1083

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  44 in total

Review 1.  The coregulator exchange in transcriptional functions of nuclear receptors.

Authors:  C K Glass; M G Rosenfeld
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 2.  Role of protein methylation in chromatin remodeling and transcriptional regulation.

Authors:  M R Stallcup
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

Review 3.  Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology.

Authors:  Subhamoy Dasgupta; Bert W O'Malley
Journal:  J Mol Endocrinol       Date:  2014-07-14       Impact factor: 5.098

4.  Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation.

Authors:  Yanzhong Yang; Kevin M McBride; Sean Hensley; Yue Lu; Frederic Chedin; Mark T Bedford
Journal:  Mol Cell       Date:  2014-02-06       Impact factor: 17.970

5.  Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities.

Authors:  S S Koh; D Chen; Y H Lee; M R Stallcup
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  Synergistic, p160 coactivator-dependent enhancement of estrogen receptor function by CARM1 and p300.

Authors:  D Chen; S M Huang; M R Stallcup
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

7.  Methylation of histone H3 by coactivator-associated arginine methyltransferase 1.

Authors:  B T Schurter; S S Koh; D Chen; G J Bunick; J M Harp; B L Hanson; A Henschen-Edman; D R Mackay; M R Stallcup; D W Aswad
Journal:  Biochemistry       Date:  2001-05-15       Impact factor: 3.162

8.  Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Jiyoung Kim; Xiaoling Yang; Jennifer L Martindale; Kumiko Tominaga-Yamanaka; Elizabeth J White; Arturo V Orjalo; John L Rinn; Stefan G Kreft; Gerald M Wilson; Myriam Gorospe
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.

Authors:  Lu Wang; Zibo Zhao; Mark B Meyer; Sandeep Saha; Menggang Yu; Ailan Guo; Kari B Wisinski; Wei Huang; Weibo Cai; J Wesley Pike; Ming Yuan; Paul Ahlquist; Wei Xu
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

10.  An AUTS2-Polycomb complex activates gene expression in the CNS.

Authors:  Zhonghua Gao; Pedro Lee; James M Stafford; Melanie von Schimmelmann; Anne Schaefer; Danny Reinberg
Journal:  Nature       Date:  2014-12-18       Impact factor: 49.962

View more
  5 in total

Review 1.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

2.  RNA-Binding RING E3-Ligase DZIP3/hRUL138 Stabilizes Cyclin D1 to Drive Cell-Cycle and Cancer Progression.

Authors:  Srinivasa P Kolapalli; Rinku Sahu; Nishant R Chauhan; Kautilya K Jena; Subhash Mehto; Saroj K Das; Ashish Jain; Manaswini Rout; Rupesh Dash; Rajeeb K Swain; David Y Lee; Tor Erik Rusten; Santosh Chauhan; Swati Chauhan
Journal:  Cancer Res       Date:  2020-10-16       Impact factor: 13.312

3.  Transcriptomic Analysis Identifies RNA Binding Proteins as Putative Regulators of Myelopoiesis and Leukemia.

Authors:  Subha Saha; Krushna Chandra Murmu; Mayukh Biswas; Sohini Chakraborty; Jhinuk Basu; Swati Madhulika; Srinivasa Prasad Kolapalli; Santosh Chauhan; Amitava Sengupta; Punit Prasad
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

4.  The A to I editing landscape in melanoma and its relation to clinical outcome.

Authors:  Austeja Amweg; Marina Tusup; Phil Cheng; Ernesto Picardi; Reinhard Dummer; Mitchell P Levesque; Lars E French; Emmanuella Guenova; Severin Läuchli; Thomas Kundig; Mark Mellett; Steve Pascolo
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

5.  EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer.

Authors:  Igor Katsyv; Minghui Wang; Won Min Song; Xianxiao Zhou; Yongzhong Zhao; Sun Park; Jun Zhu; Bin Zhang; Hanna Y Irie
Journal:  Oncotarget       Date:  2016-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.